1. Colchicine and Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Author
-
Wang MK, Razeghi G, Eikelboom JW, Devereaux PJ, Budgeon CA, Jacka MJ, Wright DJ, Latini R, and Conen D
- Subjects
- Humans, Risk Factors, Colchicine adverse effects, Colchicine therapeutic use, Randomized Controlled Trials as Topic, Venous Thromboembolism prevention & control, Venous Thromboembolism epidemiology
- Abstract
Competing Interests: Disclosures D.C. received research grants from the Canadian Institutes of Health Research, speaker fees from Servier outside of the current study, and advisory board fees from Roche Diagnostics and Trimedics outside of the current study. P.J.D. is a member of a research group with a policy of not accepting honoraria or other payments from industry for own personal financial gain. They do accept honoraria or payments from industry to support research endeavours and costs to participate in meetings. Based on study questions that P.J.D. originated and grants he has written, he has received grants from Abbott Diagnostics, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Cloud DX, Coviden, Octapharma, Philips Healthcare, Roche Diagnostics, Siemens, and Stryker. He has also participated in an advisory board meeting for GlaxoSmithKline and an expert panel meeting with AstraZeneca, Boehringer Ingelheim, and Roche. M.K.W. holds the PSI Foundation Research Trainee Award. DJ.W. has been a consultant for Boston Scientific, Medtronic and iRhythm. The remaining authors have no conflicts of interest to disclose.
- Published
- 2024
- Full Text
- View/download PDF